NEW DELHI: Bharat Biotech’s Covaxin has shown 77.8% effectiveness in phase 3 trials, also reported ANI pruning resources.
The Hyderabad-based company had previously submitted the trial information to the Subject Expert Committee (SEC) of the Indian medication regulator.
The panel has accepted the trial information.
The trials have been conducted 25,800 subjects, according to reports.
Bharat Biotech’s indigenously developed Covaxin is among the 3 vaccines currently being used in India.
Covishield, produced by AstraZeneca and fabricated locally by Serum Institute of India and also Russia’s Sputnik V would be another two vaccines administered The firm has established the vaccine from conjunction with the Indian Council of Medical Research (ICMR).
Ludhiana: The police have submitted FIR to four identified and at least 40 unknown attackers…
Sonīpat / Ludhiana / Ambala: Actor Punjabi - Activist Activist Deep Sidhu, who died in…
PATIALA / MANSA / BARNALA: Attacking Prime Minister Narendra Modi and AAP National Convener Kejriawal,…
Jalandhar: BJP and AAM AAM AADMI parties are one party, Secretary General of the Ajay…
Ludhiana: Minister of Union Culture Meenakshi Lekhi while campaigning to support the BJP candidate from…
Machhiwara (Ludhiana): AAM AAM AADMI Party (AAP) Head of Punjab Candidate and Members of Parliament…